Zusammenfassung
Die Zöliakie (Synonyme: „Einheimische Sprue“, „Glutensensitive Enteropathie“) ist eine häufige immun-mediierte Erkrankung des Intestinums. Große Studien in Europa und den USA zeigen eine Prävalenz von nahezu 1 % in der Gesamtbevölkerung (Green et al., 2003; Fasano et al., 2003; Tommasini et al., 2004). Die Häufigkeit der Zöliakie wurde in Nord- und Südamerika, Europa, Nord-Afrika, im Süden und Westen Asiens wie auch in Australien mit 1 : 130 bis 1 : 300 dokumentiert (Fasano et al., 2001; Green et al., 2003). Der Zöliakie liegt eine genetisch bedingte T-Zell-vermittelte Immunantwort gegen die Gliadinfraktion (Prolin- und Glycin-reiche Proteinfraktion) des Weizenproteins Gluten und verwandten alkohollöslichen Proteinen aus Roggen und Gerste zugrunde (Shan et al., 2002). Gluten und verwandte Moleküle verursachen eine grundsätzlich reversible entzündliche Reaktion mit lymphozytärer Infiltration der Dünndarmschleimhaut (Green et al., 2003).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
Alaedini A, Green PH (2005) Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 142(4): 289–298
Bhatia KP, Brown P, Gregory R, Lennox GG, Manji H, Thompson PD, Ellison DW, Marsden CD (1995) Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 118: 1087–1093
Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY (2006) Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med 130(7): 1020–1025
Bürk K, Bösch S, Müller CA, Melms A, Zühlke C, Stern M, Besenthal I, Skalej M, Ruck P, Ferber S, Klockgether T, Dichgans J (2001) Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124: 1013–1019
Bürk K, Melms A, Schulz JB, Dichgans J (2001) Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol 50(6): 827–828
Buzzetti R, Quattrocchi CC, Nistico L (1998) Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence. Diabetes Metab Rev 14: 111–128
Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, Latov N (2003) Celiac neuropathy. Neurology 60(10): 1581–1585
Collin P, Kaukinen K, Valimaki M, Salmi J (2002) Endocrinological disorders and celiac disease. Endocr Rev 23: 464–483
Dalton TA, Bennett JC (1992) Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 92: 183–188
Dandalides SM, Carey WD, Petras R, Achkar E (1989) Endoscopic small bowel mucosal biopsy: a controlled trial evaluating forceps size and biopsy location in the diagnosis of normal and abnormal mucosal architecture. Gastrointest Endosc 35: 197–200
Della Nave R, Magaudda A, Michelucci R, Capizzi G, Calabrò A, Guerrini L, Gavazzi C, Diciotti S, Riguzzi P, Daniele O, Villari N, Tassinari CA, Mascalchi M (2007) Whole-brain histogram and voxel-based analyses of apparent diffusion coefficient and magnetization transfer ratio in celiac disease, epilepsy, and cerebral calcifications syndrome. AJNR Am J Neuroradiol 28(3): 479–485
Fasano A, Catassi C (2001) Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120: 636–651
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wassermann SS, Murray JA, Horvath K (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163: 286–292
Gibbons CH, Freeman R (2005) Autonomic neuropathy and coeliac disease. J Neurol Neurosurg Psychiatry 76(4): 579–581
Gobbi G (2005) Coeliac disease, epilepsy and cerebral calcifications. Brain Dev 27(3): 189–200
Green PH, Jabri B (2003) Coeliac disease. Lancet 362: 383–391
Green PH, Cellier C (2007) Celiac disease. N Engl J Med 357(17): 1731–43
Hadjivassiliou M, Grünewald R, Sharrack B, Sanders D, Lobo A, Williamson C, Woodroofe N, Wood N, Davies-Jones A (2003) Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 126: 685–691
Hadjivassiliou M, Grünewald RA, Kandler RH, Chattopadhyay AK, Jarratt JA, Sanders DS, Sharrack B, Wharton SB, Davies-Jones GA (2006) Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry 77(11): 1262–1266
Hadjivassiliou M, Kandler RH, Chattopadhyay AK, Davies-Jones AG, Jarratt JA, Sanders DS, Sharrack B, Grünewald RA (2006) Dietary treatment of gluten neuropathy. Muscle Nerve 34(6): 762–766
Hadjivassiliou M, Mäki M, Sanders DS, Williamson CA, Grünewald RA, Woodroofe NM, Korponay-Szabó IR (2006) Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 66(3): 373–377
Lock RJ, Pengiran Tengah DS, Unsworth DJ, Ward JJ, Wills AJ (2005) Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guilt by association? J Neurol Neurosurg Psychiatry 76(11): 1601–1603
Martínez-Bermejo A, Polanco I, Royo A, López-Martín V, Arcas J, Tendero A, Fernández-Jaén A, Pascual-Castroviejo I (1999) A study of Gobbi’s syndrome in Span?ish population. Rev Neurol 29(2): 105–110
Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297: 2275–2279
Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, Berti I, Neri E, Gerarduzzi T, Bruno I, Lenhardt A, Zamuner E, Spano A, Crovella S, Martellossi S, Torre G, Sblattero D, Marzari R, Bradbury A, Tamburlini G, Ventura A (2004) Mass screening for coeliac disease us?ing antihuman transglutaminase antibody assay. Arch Dis Child 89: 512–515
Trier JS (1991) Celiac sprue. N Engl J Med 325(24): 1709–1719
Vaknin A, Eliakim R, Ackerman Z, Steiner I (2004) Neurological abnormalities associated with celiac disease. J Neurol 251(11): 1393–1397
Wiendl H, Mehling M, Dichgans J, Melms A, Bürk K (2003) The humoral response in the pathogenesis of gluten ataxia. Neurology 60(8): 1397–1399
Literaturverzeichnis
Aldrich M (1993) Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 17: 192–196
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J and the Restless legs syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health and the International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101–119
American Academy of Sleep Medicine (2005) ICSD-2 — International classification of sleep disorders, 2nd edition. Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester
Arendt J, Stone B, Deborah J (2005) Skine Sleep Disruption in Jet-Lag and other circadian rhythm related disorders. In: Kryger M, Roth Th, Dement W (eds) Principles and Practice of Sleep Medicine, 4th Edition. Saunders, Philadelphia, pp 659–672
Aschoff J, von Goetz C, Wildgruber C, Wever RA (1986) Meal timing in humans during isolation without time cues. J Biol Rhythms 1: 151–162
Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB (2003) A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163: 205–209
Benka R, Schenck R (2005) Sleep and Eating Disorders. In: Kryger M, Roth Th, Dement W (eds) Principles and Practice of Sleep Medicine, 4th Edition. Saunders, Philadelphia, pp 1337–1343
Bjorvatn B, Sagen I, Oyande N, Waage S, Fetveit A, Pallesen S, Ursin R (2007) the association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res 16: 66–76
Block G (2005) Keep Time, Stay Healthy. Sci Aging Knowl Environ 19: pe13 (review)
Borbely AA (1982) A two process model of sleep regulation. Hum Neurobiol 1: 195–204
Burdakov D, Alexopoulos H (2005) Metabolic state signal-ling through central hypoctetin/orexin neurons. J Cell Moll Med 9: 795–803
Burdakov D, Gerasimenko O, Verkhratsky A (2005) Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci 25: 2429–2433
Chaput J, Després J, Bouchard C, Tremblay A (2008) The Association Between Sleep Duration and Weight Gain in Adults: A 6-Year Prospective Study from the Quebec Family Study. Sleep 31: 517–523
Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437–451
Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, Ronda JM, Silva EJ, Allan JS, Emens JS, Dijk DJ, Kronauer RE (1999) Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284: 2177–2181
Danguir J, Nicolaidis S (1979) Dependence of sleep on nutrients’ availability. Physiol Behav 22: 735–740
De Lecea L, Jones B, Boutral B, Borgland St, Nishino S, Bubser M, DiLeone R (2006) Addiction and Arousal: Alternative Roles of Hypothalamic Peptides. J Neuroscie 26: 10372–10375
Dean T Jr, Allen RP, O’Donell CP, Earley CJ (2006) The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med 7: 634–640
Dingemanse J, Dorffner G, Hajak B, Benes H, Danker-Hopfe H, Polo O, Saletu B, Barbanoj M, Pillar G, Penzel Th, Chiossi E, Hoever P (2007) Proof-of-concept study in primary insomnia patients with ACT-078573, a dual orexin receptor antagonist. Sleep and Biological Rhythms S1: A1–A219
Fahey D, Zee PC (2008) Circadian rhythm disorders. In: Smith HR, Comella CL, Högl B (eds) Sleep Medicine. Cambridge University Press, New York, pp 56–77
Frauscher B, Gschliesser V, Brandauer E, Ulmer H, Peralta CM, Müller J, Poewe W, Högl B (2007) Video analysis of motor events in REM slepp behavior disorder. Mov Disord 22: 1464–1470
Fronczek R, Overeem S, Reijntjes R, Lammers GJ, van Dijk JG, Pijl H (2008) Increased Heart Rate Variability but Normal Resting Metabolic Rate in Hypocretin/Orexin-deficient Human Narcolepsy. J Clin Sleep Med 4: 248–254
Harnish MJ, Greenleaf SR, Orr WC (1998) A comparison of feeding to cephalic stimulation on postprandial sleepiness. Physiol Behav 64: 93–96
Högl B, Poewe W (2003) Sleep and daytime sleepiness in Parkinson’s disease. Swiss Archives of Neurology and Psychiatry 154: 374–383
Högl B, Winkelmann J, Trenkwalder C (2008) Restless Legs Syndrome. J Neurology, in press
Knutson K, Ryden A, Mander B, van Cauter E (2006) Role of Sleep Duration and Quality in the Risk and Severity of Type 2 Diabetes Mellitus. Arch Intern Med 166: 1768–1774
Kohatsu ND, Tsai R, Young T, Vangilder R, Burmeister LF, Stromquist AM, Merchant JA (2006) Sleep duration and body mass index in a rural population. Arch Intern Med 166: 1701–1705
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59: 131–136
Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365–376
Mayer G, Kesper K, Peter H, Pioch T, Leinweber T, Peter JH (2002) Comorbidity in narcoleptic patients. Dtsch Med Wochenschr 127: 1942–1946
Mignot E (2005) Narkolepsie: Pharmacology, Pathophysiology and Genetics. In: Kryger M, Roth Th, Dement W (Hrsg) Principles and Practice of Sleep Medicine, 4th Edition. Saunders, Philadelphia, pp 761–779
Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59: 1553–1562
Mokhlesi B, Gozal D (2008) Adult and pediatric sleep-disordered breathing: a virtual symposium. Introduction. Proc Am Thorac Soc 5: 135
Morgenthaler TI, Silber MH (2002) Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 3: 323–327
Moser M, Frühwirth M, Kenner T (2008) The symphony of life. Importance, interaction, and visualization of biological rhythms. IEEE Eng Med Biol Mag 27: 29–37
Nicolaidis S (2006) Metabolic mechanism of wakefulness (and hunger) and sleep (ans satiety): role of adenosine triphosphate and hypocretin and other peptides. Met Clin and Experim 55(Suppl 2): S24–S29
Orr W (2005) Gastrointestinal Disorders. In: Kryger M, Roth Th, Dement W (Hrsg) Principles and Practice of Sleep Medicine, 4th Edition. Saunders, Philadelphia, S 1256–1265
Orr W, Shadid G, Harnish M, Elsenbruch S (1997) Meal Composition and Its Effect on Postprandial Sleepiness. Physiology & Behavior 62: 709–712
Orr WC, Harnish MJ (1998) Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 12: 1033–1038
Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991–997
Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 2(Suppl.): S303–S309
Podestá C, Ferreras M, Mozzi M, Bassetti C, Dauvilliers Y, Billiard M (2006) Kleine-Levin syndrome in a 14-year-old girl: CSF hypocretin-1 measurements. Sleep Med 7: 649–651
Randerath WJ, Stieglitz S, Galetke W, Laumanns C, Duchna HW, Schäfer T (2008) Pathophysiology of the Obesity Hypoventilation Syndrome. Pneumologie 62: 398–403
Scheen A, Byrne M, Plat L, Leproult R, van Cauter E (1996) Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol Endocrinol Metab 271: E261–E270
Schuld A, Beitinger PA, Dalal M, Geller F, Wetter Th, Albert Ed, Hebebrand J, Pollmächer T (2002) Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers. Sleep Med 3: 335–339
Schuld A, Blum WF, Uhr M, Haack M, Kraus T, Holsboer F, Pollmächer T (2000) Reduced leptin levels in human narcolepsy. Neuroendocrinology 72: 195–198
Schuld A, Hebebrand J, Geller F, Pollmächer T (2000) Increased body-mass index in patients with narcolepsy. Lancet 355: 1274–1275
Schwab RJ (2005) Genetic determinants of upper airway structures that predispose to obstructive sleep apnea. Respir Physiol Neurobiol 147: 289–298
Schwartz AR, Patil SP, Laffan AM, Polotsky V (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5: 185–192
Singh M, Drake C, Roehrs T, Hudgel D, Roth T (2005) The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med 1: 357–363
Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435–1439
Spiegel K, Tasali E, Penev P, van Cauter E (2004) Brief Communication: Sleep curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite. Arch Intern Med 141: 846–850
Taheri Sh, Lin L, Austin D, Young T, Migno E (2004) Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index. PLoS Medicine 1: 210–217
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469–474
Thie NM, Kato T, Bader G, Montplaisir JY, Lavigne GJ (2002) The significance of saliva during sleep and the relevance of oromotor movements. Sleep Med Rev 6: 213–227
Trenell M, Marshall N, Rogers NL (2007) Sleep and metabolic control: waking to a problem? Clin exp pharmacol physiol 34: 1–9
Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J (2005) Obesity and metabolic syndrome in circadian clock mutant mice. Science 308: 1043–1045
Van Cauter E, Desir D, Decoster C, Féry F, Balasse E (1989) Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab 69: 604–611
VanItallie T (2006) Sleep and energy balance: interactive homeostatic systems. Metabolism Clinical and Experimental 55(Suppl): S30–S35
Volk S, Simon O, Schulz H, Hanser E, Wilde-Frenz J (1984) The structure of wakefulness and its relationship to daytime sleep in narcoleptic patients. Electroencephalogr Clin Neurophysiol 57: 119–128
Vorona RD, Ware JC (2002) Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report. Sleep Med 3: 365–367
Weinstock L, Fern S, Duntley S (2007) Restless Legs Syndrome in Patients with Irritable Bowel Syndrome: Response to Small Intestinal bacterial Overgrowth Therapy. Dig Dis Sci 53: 1252–1256
Winkelman JW (2006 a) Sleep-related eating disorder and night eating syndrome: sleep disorders, eating disorders, or both? Sleep 29: 876–877
Winkelman JW (2006 b) Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry 67: 1729–1734
Yaggi H, Araujo A, McKinlay J (2006) Sleep Duration as a Risk Factor for the Development of Type 2 Diabetes. Diabetes Care 29: 657–661
Literaturverzeichnis
Ascherio A, Munger KL (2007 a) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61: 288–299
Ascherio A, Munger KL (2007 b) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61: 504–513
Bauer H (1994) Schriftenreihe der DMSG: MS-Information Nr. 2.7.2 Diätische Leitlinien für MS-Betroffene. Deutsche Multiple Sklerose Gesellschaft, Bundesverband e. V., Hannover
Baumhackl U, Eibl G, Ganzinger U, Hartung HP, Mamoli B, Pfeiffer KP, Fazekas F, Vass K (2002) Prevalence of multiple sclerosis in Austria. Results of a nationwide survey. Neuroepidemiology 21: 226–234
Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346: 158–164
Compston A, McDonald WI, Noseworthy J, Lassmann H, Miller DH, Smith KJ, Wekerle H, Confavreux C (2005) McAlpine’s Multiple Sclerosis, 4th edition edn. Churchill Livingstone, London
Giovannoni G, Ebers G (2007) Multiple sclerosis: the environment and causation. Curr Opin Neurol 20: 261–268
Goldberg P (1974) Multiple Sclerosis-Vitamin D and Calcium as Environmental Determinants of Prevalence (a Viewpoint).1. Sunlight, Dietary Factors and Epidemiology. International Journal of Environmental Studies 6: 19–27
Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21: 193–200
Hawkes CH (2007) Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 13: 610–615
Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H (2005) Cigarette smoking and the progression of multiple sclerosis. Brain 128: 1461–1465
Hernan MA, Olek MJ, Ascherio A (2001) Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154: 69–74
Kimball SM, Ursell MR, O’Connor P, Vieth R (2007) Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86: 645–651
Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210–218
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121–127
Mikaeloff Y, Caridade G, Tardieu M, Suissa S (2007) Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 130: 2589–2595
Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62: 60–65
Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44: 1687–1692
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshen-ker BG (2000) Multiple sclerosis. N Engl J Med 343: 938–952
Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, Kisic D, Kostic J (2006) Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology 27: 212–216
Riise T, Nortvedt MW, Ascherio A (2003) Smoking is a risk factor for multiple sclerosis. Neurology 61: 1122–1124
Soilu-Hanninen M, Laaksonen M, Laitinen I, Eralinna JP, Lilius EM, Mononen I (2008) A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 79: 152–157
Swank RL, Lerstad O, Strom A, Backer J (1952) Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 246: 722–728
Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105: 1296–1299
Villard-Mackintosh L, Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47: 161–168
Vukusic S, Confavreux C (2003) Primary and secondary progressive multiple sclerosis. J Neurol Sci 206: 153–155
Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112 (Pt 1): 133–146
Zhang SM, Willett WC, Hernan MA, Olek MJ, Ascherio A (2000) Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 152: 1056–1064
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Hering, S., Boesch, S., Högl, B., Reindl, M. (2010). Neurologie. In: Ledochowski, M. (eds) Klinische Ernährungsmedizin. Springer, Vienna. https://doi.org/10.1007/978-3-211-88900-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-211-88900-8_18
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-88899-5
Online ISBN: 978-3-211-88900-8
eBook Packages: Medicine (German Language)